Research Grade GLP1-like peptide conjugated to Anti-Human GIPR Antibody (AMG 133)GLP1-like peptide conjugated to Anti-Human GIPR Antibody (AMG 133) ( HW595026 ) is a research-grade recombinant antibody targeting Gastric inhibitory polypeptide receptor . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Biosimilar | | Target | Gastric inhibitory polypeptide receptor, GIPR, GIP-R, Glucose-dependent insulinotropic polypeptide receptor | | Accession | P48546 & P01275-1 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-512-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade GLP1-like peptide conjugated to Anti-Human GIPR Antibody (AMG 133).
Примечание: |
|
